Explore our state-of-the-art medical devices, endoscopic surgical instruments, and high-efficiency precision machinery manufactured under ISO 13485 protocols.
A High-Tech Enterprise Integrating R&D, Manufacturing, Sales, and Services
Zhejiang Centuri Medical Co., Ltd., is a high-tech enterprise that integrates research and development, manufacturing, sales, and after-sales services. The company is committed to innovation and production in the field of minimally invasive surgical instruments, emergency defibrillation systems, and critical care medical products, providing advanced medical solutions for the global market.
As a global pioneer in cardiac resuscitation technology and surgical equipment manufacturing, our manufacturing base spans 20,000 square meters, which includes a 5,000-square-meter Class 100,000 cleanroom and a 500-square-meter analytical testing laboratory. Equipped with a comprehensive quality management system, advanced automated manufacturing equipment, and high-precision testing routines, we ensure every unit leaving our facility adheres to rigid international efficacy standards.
Sudden Cardiac Arrest (SCA) accounts for over 15% of all global fatalities annually. Our mission centers on engineering defibrillation equipment with near-zero latency, optimal waveform efficiency, and fault-tolerant operational reliability for first responders worldwide.
Underpinned by top clinical expert consultations, proprietary invention patents, and international medical regulatory compliance.
Zhejiang Centuri Medical Co., Ltd. has successfully completed the "Medical Device Production Quality Control" and "Management Standard" system evaluations. We hold full ISO 13485 certifications. Our comprehensive portfolio—including disposable puncture devices, digital endoscopes, electrocautery instruments, staplers, and defibrillator lines—holds domestic registrations and EU CE certifications.
Boasting a multidisciplinary R&D team with over 10 years of average engineering experience, we maintain long-term technical research initiatives with leading academic medical centers. With over 50 patents spanning core algorithms, energy delivery, and ergonomic instrument design, we lead market innovation in critical care and minimally invasive surgery.
From initial local medical device registration guidance to global logistics, customized OEM/ODM design, and comprehensive post-market clinical training, our regulatory and customer service teams ensure seamless product adoption across global hospital networks and distributor portfolios.
Analyzing global demand drivers, regulatory evolutionary mandates, and the shift toward public access resuscitation infrastructure.
The global market for cardiac defibrillators—encompassing Automated External Defibrillators (AEDs), Advanced Life Support (ALS) manual monitor-defibrillators, and wearable cardioverter-defibrillators—is undergoing unprecedented expansion. Driven by an aging demographic, rising incidences of ischemic heart disease, and stringent public safety mandates, procurement by healthcare ministries and corporate entities has reached record highs.
| Geographic Region | Primary Demand Drivers | Regulatory Environment | Infrastructure Adoption Level |
|---|---|---|---|
| North America | Mandatory AED installation in commercial facilities, high EMS integration, dense placement in educational sectors. | US FDA Pre-Market Approval (PMA) stringent quality audits; transition to strict software cybersecurity guidelines. | Mature / High Density (>85% public building coverage) |
| European Union | Harmonization of resuscitation guidelines (ERC 2021/2025), expanding community responder networks. | Strict transition from MDD to EU MDR (2017/745) requiring exhaustive clinical evaluation reports. | Advanced / Systemic Mandates across Tier 1 & Tier 2 cities |
| Asia-Pacific (APAC) | Rapid modernization of healthcare infrastructure, high urban population density, government emergency initiatives. | Dynamic local regulatory frameworks (NMPA, PMDA, MFDS) requiring dedicated local registration support. | Exponential Growth Phase (High conversion in public transit & care centers) |
| Latin America & MEA | Hospital modernization programs, expansion of mining & energy industrial safety standards. | Reliance on CE/FDA equivalency certificates; rising demand for durable, multi-language localized devices. | Emerging / Industrial & Hospital Sector Prioritization |
As global regulatory bodies transition to higher compliance thresholds (such as the EU MDR and FDA PMA processes), healthcare distributors and hospital procurement units face supply chain bottlenecks. Zhejiang Centuri Medical Co., Ltd. bridge this gap by offering fully certified, highly reliable defibrillation platforms engineered for seamless international clearance and rapid market entry.
From intensive care operating suites to extreme outdoor industrial sites, our equipment is tailored for mission-critical reliability.
Designed for immediate synchronized cardioversion, external pacing, and non-invasive monitoring (SpO2, NIBP, EtCO2). Enables seamless patient transfer between trauma rooms, surgical theater suites, and cardiac care units.
Built with high IP55 ingress protection, drop resistance, and thermal tolerance. Fast-charging capacitors allow rapid shock delivery within 5 seconds during critical ambulance transit.
Extremely ruggedized chassis featuring dust-tight seals and vibration isolation. Suited for remote oil rigs, chemical plants, and heavy mining infrastructure where emergency medical rescue is hours away.
Intuitive voice prompts, multi-language real-time visual step-by-step guidance, and automatic self-testing ensure non-trained bystanders can safely deliver life-saving shocks in airports, malls, and schools.
Compliant with commercial flight radio-frequency emission standards and maritime salt-spray corrosion parameters. Ensures full cardiac response preparedness on long-haul commercial flights and cruise liners.
Ultra-compact footprints equipped with extended battery life (up to 200 shocks at 360J). Built to operate under solar glare, total darkness, and chaotic field triage scenarios.
Pioneering AI arrhythmia classification, BTE energy delivery, and IoT cloud fleet telematics.
Modern resuscitation clinical data proves that Biphasic Truncated Exponential (BTE) waveforms deliver superior defibrillation efficacy at lower peak currents compared to legacy monophasic pulses. Centuri Medical’s energy management systems auto-adjust shock voltage and pulse duration based on real-time trans-thoracic impedance measurements (20Ω to 200Ω), drastically reducing post-shock myocardial dysfunction.
Integrating machine learning neural networks trained on over 500,000 ECG arrhythmia segments. The system accurately differentiates Ventricular Fibrillation (VF) and Pulseless Ventricular Tachycardia (VT) from non-shockable rhythms in under 2 seconds. Furthermore, real-time acceleration sensors inside the defibrillator pads monitor CPR chest compression depth, rate, and recoil, providing verbal prompt adjustments.
Managing large networks of public or hospital AEDs is simplified via 5G / Wi-Fi / NB-IoT connectivity. Centralized administration dashboards automatically track self-test diagnostic reports, battery power degradation, and electrode gel expiration dates. Instant alerts prevent "silent failures" in the field, guaranteeing 99.99% readiness.
Next-generation R&D efforts at Centuri Medical are focused on lightweight, sub-1kg AED designs and wearable defibrillator vests (WCD) for high-risk post-infarction patients. Utilizing high-density lithium-manganese dioxide battery chemistry and planar transformer technologies, the future of defibrillation is unobtrusive, continuous protection.
Operating within Zhejiang's advanced medical equipment industrial cluster gives Zhejiang Centuri Medical Co., Ltd. a decisive competitive edge in manufacturing agility, cost containment, and supply chain scalability.
From SMT surface-mount PCB assembly and high-voltage capacitor winding to precision injection molding and cleanroom final assembly, key components are processed in-house to guarantee flawless quality control.
By eliminating redundant intermediary distributor markups and operating streamlined automated production lines, we provide world-class medical devices at highly competitive direct-factory pricing.
Our modular assembly architecture enables rapid scaling of production runs to meet sudden emergency procurement tenders and customized OEM volume orders without sacrificing lead times.
Empowering global distributors with customized branding, localized user interfaces, and complete regulatory dossiers.
We provide comprehensive OEM design, including custom exterior housing colorways, corporate logo silk-screening, bespoke UI design, and branded packaging solutions tailored for local market dominance.
To ensure flawless operation across international territories, our software support over 30 languages with native voice actor prompts, clear localized screen translations, and regional shock protocol pre-sets.
Our regulatory affairs department delivers full Technical Files, STED documentation, Risk Management files (ISO 14971), and Software Validation reports to expedite your local Health Ministry approvals.
Addressing technical, operational, and commercial procurement queries regarding defibrillator systems.
Discover our extended line of medical endoscopes, surgical accessories, and high-performance industrial pumps.
Zhejiang Centuri Medical Co., Ltd. is always customer-oriented, focusing on technological innovation, high-quality products, and attentive after-sales service. With a strong foundation in the domestic market, we are actively expanding into international markets and contributing to global healthcare. We look forward to collaborating with global distributors, hospitals, and medical device brands to advance resuscitation and surgical technology together.
Centuri Medical